Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Degos

Showing results (181-190 of 331) with videos related to

Pageof 34
Sort By:
La Nouvelle Presse Medicale|June 16, 1979
[Bone lesions in hairy cell leukaemia (author's transl)]H J Weh, M Katz, B Bray, et al.
Immunogenetics|January 1, 1981
Alloantigens expressed on activated human T cells different from HLA-A, B, C, and DR antigensM Gerbase de Lima, E E Wollman, V Lepage, et al.
Presse Medicale (Paris, France : 1983)|November 12, 1988
[Absence of class I HLA antigen in acute myeloblastic leukemia]S Collado, J M Miclea, S Castaigne, et al.
British Journal of Haematology|March 1, 1995
Unexpected high incidence of intracranial subdural haematoma during intensive chemotherapy for acute myeloid leukaemia with a monoblastic componentE Jourdan, H Dombret, S Glaisner, et al.
Lancet (London, England)|June 21, 1986
Pharmacokinetic data on very-low-dose cytarabineO Poirier, C Chomienne, S Castaigne, et al.
Leukemia Research|January 1, 1988
Action of interferon-alpha on hairy cell leukemia: expression of specific receptors and (2'-5')oligo (A) synthetase in tumor cells from sensitive and resistant patientsC Billard, D Ferbus, F Sigaux, et al.
International Immunology|October 1, 1994
Multiple nuclear factors bind to novel positive and negative regulatory elements upstream of the human MHC class I gene HLA-A11O Blanchet, C Gazin, M L'Haridon, et al.
Leukemia|January 1, 1995
Differential uptake of all-trans retinoic acid by acute promyelocytic leukemic cells: evidence for its role in retinoic acid efficacyA Agadir, M Cornic, P Lefebvre, et al.
Leukemia|June 1, 1994
In vitro all-trans retinoic acid (ATRA) sensitivity and cellular retinoic acid binding protein (CRABP) levels in relapse leukemic cells after remission induction by ATRA in acute promyelocytic leukemiaM Cornic, L Delva, S Castaigne, et al.
Leukemia|December 1, 1995
In vitro treatment with retinoids or the topoisomerase inhibitor, VP-16, evidences different functional apoptotic pathways in acute promyelocytic leukemic cellsC Calabresse, S Barbey, L Venturini, et al.
Pageof 34

Showing results (181-190 of 331) with videos related to

Sort By:
Pageof 34
La Nouvelle Presse Medicale|June 16, 1979
[Bone lesions in hairy cell leukaemia (author's transl)]H J Weh, M Katz, B Bray, et al.
Immunogenetics|January 1, 1981
Alloantigens expressed on activated human T cells different from HLA-A, B, C, and DR antigensM Gerbase de Lima, E E Wollman, V Lepage, et al.
Presse Medicale (Paris, France : 1983)|November 12, 1988
[Absence of class I HLA antigen in acute myeloblastic leukemia]S Collado, J M Miclea, S Castaigne, et al.
British Journal of Haematology|March 1, 1995
Unexpected high incidence of intracranial subdural haematoma during intensive chemotherapy for acute myeloid leukaemia with a monoblastic componentE Jourdan, H Dombret, S Glaisner, et al.
Lancet (London, England)|June 21, 1986
Pharmacokinetic data on very-low-dose cytarabineO Poirier, C Chomienne, S Castaigne, et al.
Leukemia Research|January 1, 1988
Action of interferon-alpha on hairy cell leukemia: expression of specific receptors and (2'-5')oligo (A) synthetase in tumor cells from sensitive and resistant patientsC Billard, D Ferbus, F Sigaux, et al.
International Immunology|October 1, 1994
Multiple nuclear factors bind to novel positive and negative regulatory elements upstream of the human MHC class I gene HLA-A11O Blanchet, C Gazin, M L'Haridon, et al.
Leukemia|January 1, 1995
Differential uptake of all-trans retinoic acid by acute promyelocytic leukemic cells: evidence for its role in retinoic acid efficacyA Agadir, M Cornic, P Lefebvre, et al.
Leukemia|June 1, 1994
In vitro all-trans retinoic acid (ATRA) sensitivity and cellular retinoic acid binding protein (CRABP) levels in relapse leukemic cells after remission induction by ATRA in acute promyelocytic leukemiaM Cornic, L Delva, S Castaigne, et al.
Leukemia|December 1, 1995
In vitro treatment with retinoids or the topoisomerase inhibitor, VP-16, evidences different functional apoptotic pathways in acute promyelocytic leukemic cellsC Calabresse, S Barbey, L Venturini, et al.
Pageof 34